Correlation Between Cipher Pharmaceuticals and Aion Therapeutic
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Aion Therapeutic, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Aion Therapeutic.
Diversification Opportunities for Cipher Pharmaceuticals and Aion Therapeutic
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cipher and Aion is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Aion Therapeutic go up and down completely randomly.
Pair Corralation between Cipher Pharmaceuticals and Aion Therapeutic
If you would invest 0.37 in Aion Therapeutic on August 26, 2024 and sell it today you would earn a total of 0.68 from holding Aion Therapeutic or generate 183.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.37% |
| Values | Daily Returns |
Cipher Pharmaceuticals vs. Aion Therapeutic
Performance |
| Timeline |
| Cipher Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aion Therapeutic |
Cipher Pharmaceuticals and Aion Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cipher Pharmaceuticals and Aion Therapeutic
The main advantage of trading using opposite Cipher Pharmaceuticals and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.| Cipher Pharmaceuticals vs. Bionoid Pharma | Cipher Pharmaceuticals vs. Centr Brands Corp | Cipher Pharmaceuticals vs. CTT Pharmaceutical Holdings | Cipher Pharmaceuticals vs. Alterola Biotech |
| Aion Therapeutic vs. Amexdrug | Aion Therapeutic vs. Antisense Therapeutics Limited | Aion Therapeutic vs. Alterola Biotech | Aion Therapeutic vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |